Patents by Inventor Daniel Lucius Vasella

Daniel Lucius Vasella has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8168616
    Abstract: The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 15, 2000
    Date of Patent: May 1, 2012
    Assignee: Novartis AG
    Inventors: William Hewitt, Daniel Lucius Vasella, Randy Lee Webb
  • Publication number: 20120016035
    Abstract: The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 19, 2011
    Publication date: January 19, 2012
    Inventors: William Hewitt, Daniel Lucius Vasella, Randy Lee Webb
  • Publication number: 20120010295
    Abstract: The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 19, 2011
    Publication date: January 12, 2012
    Inventors: William Hewitt, Daniel Lucius Vasella, Randy Lee Webb
  • Publication number: 20120004312
    Abstract: The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 19, 2011
    Publication date: January 5, 2012
    Inventors: William Hewitt, Daniel Lucius Vasella, Randy Lee Webb
  • Publication number: 20090036432
    Abstract: The invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, comprising (i) an AT1-receptor antagonist or a pharmaceutically acceptable salt thereof, and (ii) the diuretic amiloride or triameterine or a pharmaceutically acceptable salt thereof, and (iii) a further diuretic or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 26, 2008
    Publication date: February 5, 2009
    Applicant: Novartis AG
    Inventor: Daniel Lucius Vasella